7-149104255-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001001661.3(ZNF425):c.1616C>T(p.Ala539Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000101 in 1,613,424 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001001661.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF425 | NM_001001661.3 | c.1616C>T | p.Ala539Val | missense_variant | 4/4 | ENST00000378061.7 | NP_001001661.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF425 | ENST00000378061.7 | c.1616C>T | p.Ala539Val | missense_variant | 4/4 | 1 | NM_001001661.3 | ENSP00000367300.2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152120Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000320 AC: 8AN: 250172Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135550
GnomAD4 exome AF: 0.000106 AC: 155AN: 1461304Hom.: 0 Cov.: 90 AF XY: 0.0000990 AC XY: 72AN XY: 726986
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152120Hom.: 0 Cov.: 34 AF XY: 0.0000404 AC XY: 3AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2021 | The c.1616C>T (p.A539V) alteration is located in exon 4 (coding exon 4) of the ZNF425 gene. This alteration results from a C to T substitution at nucleotide position 1616, causing the alanine (A) at amino acid position 539 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at